- Home
- PALI vs OSUR Comparison
PALI vs OSUR Comparison
Compare PALI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PALI | OSUR |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.7M | 295.7M |
| IPO Year | 2019 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PALI | OSUR |
|---|---|---|
| Price | $2.03 | $4.27 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | ★ $11.29 | $3.00 |
| AVG Volume (30 Days) | ★ 4.7M | 553.5K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.06 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $260,000.00 | ★ $167,064,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $0.55 | $2.08 |
| 52 Week High | $2.86 | $4.58 |
Technical Indicators
Market Signals| Indicator | PALI | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 54.01 | 53.32 |
| Support Level | $1.57 | $4.19 |
| Resistance Level | $2.16 | $4.33 |
| Average True Range (ATR) | 0.18 | 0.14 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 47.06 | 18.57 |
Price Performance
Historical ComparisonAbout PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.